Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 5/29/18 → 6/30/22 |
Funding
- SynteractHCR, Inc. (Prot #CO-338-085 // Prot #CO-338-085)
- Clovis Oncology, Inc. (Prot #CO-338-085 // Prot #CO-338-085)
Prot #CO-338-085: ATLAS: A Phase 2, Open-label Study of Rucaparib in Patients with Locally Advanced or Metastatic Urothelial Carcinoma
- Morgans, Alicia Katherine (PD/PI)
Project: Research project